Skip to main content

Home

  • Home
  • Hot
  • New
  • Opinions
  • Media
    • The Times of Israel
    • The Yeshiva World
    • Voz Iz Neias
    • Matzav
  • Home
  • Japanese pharmaceutical firm taps Israel’s CytoReason for AI drug development
30 Sep

Japanese pharmaceutical firm taps Israel’s CytoReason for AI drug development

By admin 0 Comments

Tel Aviv-based startup uses machine learning to build computational models of human immune system and diseases to speed up treatments

Details
Vote up!
Vote down!

Points: 0

Category: 
Startup Israel
CytoReason
drug discovery
pharmaceuticals
Japan
  • Log in or register to post comments

Author

anon

admin

Hot

  • Herzog Visits Weizmann Institute After Missile Attack
  • IDF Issues Urgent Evacuation Warning for Arak, Khandab Ahead of Strikes on Iran’s Nuclear, Military Sites
  • Iran Shifts Tactics: Lone Missiles, Minimal Warnings in Overnight Attacks on Israel

User login

  • Create new account
  • Request new password

Recent comments

No comments available.